At a glance
We’re excited to connect with you at this conference.
Meet the Prosigna team and learn how the Prosigna Breast Risk of Recurrence test helps guide informed personalized treatment decisions for early-stage, hormone receptor positive (HR+), breast cancer.
Check back soon for details on presentations, posters, and any booth activities.
Meet with us
Interested in connecting with our team at this event? We’d love to hear from you.
Tags
North America
Prosigna Breast